Redeye: Stille Q1 2024 - Another stable quarter
Redeye upgrades its base case and forecasts following a solid Q1 report from Stille. The acqusition of Fehling is now fully incorporated and synergies is likely to start materializing throughout 2024 and beyond, providing good prospects for continued organic growth.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/